The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
| Business Activity | PASS |
| Debt Ratio (0.20%) | PASS |
| Cash Ratio (0.02%) | PASS |
| Receivables Ratio (0.23%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-07-30 | 7.56 | Pending | — |
| 2026-04-30 | 7.61 | 7.79 | +2.4% |
| 2026-02-05 | 7.88 | 8.08 | +2.5% |
| 2025-10-30 | 7.64 | 7.83 | +2.5% |
| 2025-07-31 | 7.15 | 7.20 | +0.7% |
| 2025-05-02 | 6.35 | 6.74 | +6.2% |
| 2025-01-30 | 7.82 | 6.64 | -15.1% |
| 2024-10-31 | 7.25 | 7.51 | +3.5% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-03-31 | $273.2B | $3.3B | $7.6B | $25.1B | $7.1B | 12.60 |
| 2025-12-31 | $72.4B | $1.2B | — | — | — | 4.64 |
| 2025-09-30 | $69.5B | $1.9B | $3.3B | $6.1B | $2.3B | 7.02 |
| 2025-06-30 | $66.9B | $1.5B | $3.0B | $5.9B | $2.1B | 5.76 |
| 2025-03-31 | $65.5B | $1.3B | $4.7B | $6.4B | $1.7B | 9.76 |
| 2024-12-31 | — | — | $3.0B | $6.2B | $1.9B | — |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-05-13 | CORDANI DAVID M | Chief Executive Officer | 212,543 | $36.2M |
| 2026-05-12 | CORDANI DAVID M | Chief Executive Officer | 201,878 | $59.1M |
| 2026-04-22 | MAZZARELLA KATHLEEN M. | Director | 782 | — |
| 2026-04-22 | FOSS ERIC J. | Director | 782 | — |
| 2026-04-22 | ZARCONE DONNA F | Director | 782 | — |
| 2026-04-22 | HENNIGAN MICHAEL J | Director | 782 | — |
| 2026-04-22 | WISEMAN ERIC C | Director | 782 | — |
| 2026-04-22 | KURIAN GEORGE | Director | 782 | — |
| 2026-04-22 | MCCLELLAN MARK B | Director | 782 | — |
| 2026-04-22 | ROSS KIMBERLY A | Director | 782 | — |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Blackrock Inc. | 22.6M | $6.5B | 0.1% |
| Vanguard Capital Management LLC | 17.1M | $4.9B | 0.1% |
| State Street Corporation | 12.3M | $3.5B | 0.0% |
| Massachusetts Financial Services Co. | 11.6M | $3.3B | 0.0% |
| Dodge & Cox Inc. | 11.6M | $3.3B | 0.0% |
| FMR, LLC | 11.0M | $3.1B | 0.0% |
| Sanders Capital, LLC | 10.3M | $2.9B | 0.0% |
| Geode Capital Management, LLC | 6.2M | $1.8B | 0.0% |
| Vanguard Portfolio Management LLC | 6.2M | $1.8B | 0.0% |
| GQG Partners LLC | 6.0M | $1.7B | 0.0% |
Buy
Hold
Sell
Strong Sell
$99.0B
1.79
0.313
24
$277.9B
$30.9B
+29.1%
2.1%
1.50
4.26
0.0%
65,669
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-07-30 | $7.56 | Pending | — |
| 2026-04-30 | $7.61 | $7.79 | +2.4% |
| 2026-02-05 | $7.88 | $8.08 | +2.5% |
| 2025-10-30 | $7.64 | $7.83 | +2.5% |
| 2025-07-31 | $7.15 | $7.20 | +0.7% |
| 2025-05-02 | $6.35 | $6.74 | +6.2% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($341.75, 24 analysts) | |||
| 10 | $2,873.65 | +$543.80 (19%) | 1.3R |
| 50 | $14,368.25 | +$2,719.00 (19%) | 1.3R |
| 100 | $28,736.50 | +$5,438.00 (19%) | 1.3R |
| To Fair Value ($402.56) | |||
| 10 | $2,873.65 | +$1,151.90 (40%) | 2.7R |
| 50 | $14,368.25 | +$5,759.50 (40%) | 2.7R |
| 100 | $28,736.50 | +$11,519.00 (40%) | 2.7R |
- Elevated short interest (4.26 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| ELV | 0.463 |
| CVS | 0.447 |
| BAX | 0.442 |
| XLV | 0.381 |
| UNH | 0.360 |
| Ticker | Correlation |
|---|---|
| QIC.KW | -0.272 |
| PAPER.KW | -0.212 |
| LPTVQ | -0.193 |
| CLEANING.KW | -0.177 |
| VIA | -0.160 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker’s recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.
Related Tickers
Similar in Healthcare
Also in TE500